Nevada-AACE Endocrinology for the Non-Endocrinologist & 2018 Annual Meeting

RENO, NV US
October 5, 2018 to October 7, 2018

Welcome, and thank you for attending the Nevada-AACE Endocrinology for the Non-Endocrinologist and Annual Meeting.

The Nevada Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

http://syllabus.aace.com/2018/Chapters/Nevada/index.html

Target Audience

Primary care physicians, family practitioners, internists, and allied health professionals in and surrounding the Reno, NV area, as well as clinical endocrinologists, MD/DOs, advance practice clinicians in Nevada and California interested in endocrine disease states.

Learning Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  2. Review the diagnostic workup for hypercalcemia
  3. Review the management of primary hyperparathyroidism
  4. Review the management of hypoparathyroidism
  5. Definition of osteoporosis and risk factors
  6. Treatment and risk factors for treatment failure
  7. Evidence for change of therapy
  8. Rational and approach to drug holiday
  9. Reviewing the epidemiology and pathogenesis of functioning and non-functioning pituitary tumors
  10. Overviewing the evaluation and management of pituitary tumors
  11. Discussing the approach to pituitary incidentalomas
  12. Review appropriate strategies for the evaluation and surveillance of incidental adrenal masses
  13. Review screening strategies for the detection of Cushing’s Syndrome
  14. Review screening strategies for the detection of hyperaldosteronism
  15. How to decide if treatment is indicated
  16. Who to use it in - men, women and what ages
  17. How does testosterone treatment affect the heart
  18. Understand the significance of incidental thyroid nodules
  19. Understand the indications for thyroid biopsy
  20. Review thyroid nodule evaluation algorithm
  21. Review the essentials of diagnosing and treating hypothyroidism in the primary care setting and when to refer to an endocrinologist
  22. Review the essentials of diagnosing and treating hyperthyroidism in the primary care setting and when to refer to an endocrinologist
  23. Discuss the approach to treating special circumstances in hypothyroidism and hyperthyroidism, such as pregnancy, and drug-associated thyrotoxicosis
  24. Describe the limitations of using LDL-C as the target for therapy in patients with diabetes
  25. Identify the usefulness of using Non-HDL-C, TC/HDL-C ratio and APO-B as predictors of cardiovascular disease risk
  26. Recommend various treatment modalities (therapeutic life-style changes, genetics, non-invasive testing, inflammatory biomarkers, and drug therapy) that can reduce cardiovascular disease
  27. Understand the trends and approach to patients with excessive weight
  28. Understand the concept of metabolic adaptation as it applies to maintenance of weight loss
  29. Appreciate the surgical and pharmaceutical options which may enhance weight loss
  30. Be familiar with the AACE Type 2 Diabetes algorithm
  31. Be familiar with some of the new medications to treat diabetes
  32. Be familiar with some of the new technologies to help manage diabetes
  33. Discuss the clinical presentation and treatment of osteogenesis imperfecta
  34. Discuss the clinical presentation and treatment of hypophosphatasia, specifically the adult form
  35. Discuss the clinical presentation and treatment of fibrous dysplasia
  36. Determine CV risk in diabetic patients
  37. Understand the various guidelines for lipid management
  38. Comprehend the various medical options for risk reduction
  39. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Obesity
Parathyroid & Bone
Thyroid
Course summary
Available credit: 
  • 9.50 AMA
  • 9.50 Attendance
Course opens: 
10/05/2018
Course expires: 
10/07/2019
Event starts: 
10/05/2018 - 7:00pm
Event ends: 
10/07/2018 - 12:10pm
Cost:
$0.00

PROGRAM AGENDA

ATLANTIS CASINO HOTEL
3800 S. VIRGINIA ST.
RENO, NV 89502

Friday, October 5, 2018

7:00 – 9:00 PM

Welcome Reception

Saturday, October 6, 2018 – Endocrinology for the Non-Endocrinologist

7:00 – 7:50 AM

Registration and Continental Breakfast

7:50 – 8:00 AM

Welcome

SECTION 1: BONE AND CALCIUM

8:00 – 8:10 AM

Pre-Section Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
8:10 – 8:40 AM

Hypercalcemia and Parathyroid Disorders
W. Reid Litchfield, MD, FACE, ECNU
Objectives

  1. Review the diagnostic workup for hypercalcemia
  2. Review the management of primary hyperparathyroidism
  3. Review the management of hypoparathyroidism
8:40 – 9:10 AM

Osteoporosis
Fariba Rahnema, MD, CDE, ECNU
Objectives

  1. Definition of osteoporosis and risk factors
  2. Treatment and risk factors for treatment failure
  3. Evidence for change of therapy
  4. Rational and approach to drug holiday
9:10 – 9:25 AM

Cases / Q and A

9:25 – 9:30 AM

Post Section Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
9:30 – 10:00 AM

Break

SECTION 2: SELECTED TOPICS

10:00 – 10:10 AM

Pre-Section Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
10:10 – 10:40 AM

Pituitary Tumors and Incidentalomas
Bijan Ahrari, MD, FACE, ECNU
Objectives

  1. Reviewing the epidemiology and pathogenesis of functioning and non-functioning pituitary tumors
  2. Overviewing the evaluation and management of pituitary tumors
  3. Discussing the approach to pituitary incidentalomas
10:40 – 11:10 AM

Adrenal Disorders
Quang Nguyen, DO, FACE
Objectives

  1. Review appropriate strategies for the evaluation and surveillance of incidental adrenal masses
  2. Review screening strategies for the detection of Cushing’s Syndrome
  3. Review screening strategies for the detection of hyperaldosteronism
11:10 – 11:40 AM

Hypogonadism and Testosterone Treatment
John Seibel, MD, FACP, MACE
Objectives

  1. How to decide if treatment is indicated
  2. Who to use it in - men, women and what ages
  3. How does testosterone treatment affect the heart
11:40 – 11:55 AM

Cases / Q and A

11:55 – 12:00 PM

Post Section Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
12:00 – 12:20 PM

Break

12:20 – 2:00 PM

Working Lunch

SECTION 3: THYROID

12:20 – 12:30 PM

Pre-Section Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
12:30 – 1:00 PM

Evaluation and Management of Thyroid Nodules
Nick Vernetti, MD, FACE
Objectives

  1. Understand the significance of incidental thyroid nodules
  2. Understand the indications for thyroid biopsy
  3. Review thyroid nodule evaluation algorithm
1:00 – 1:40 PM

Hypothyroidism and Hyperthyroidism
Paul Tomasic, MD, MS, FACP, FACE
Objectives

  1. Review the essentials of diagnosing and treating hypothyroidism in the primary care setting and when to refer to an endocrinologist
  2. Review the essentials of diagnosing and treating hyperthyroidism in the primary care setting and when to refer to an endocrinologist
  3. Discuss the approach to treating special circumstances in hypothyroidism and hyperthyroidism, such as pregnancy, and drug-associated thyrotoxicosis
1:40 – 1:55 PM

Cases / Q and A

1:55 – 2:00 PM

Post Section Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.

SECTION 4: LIPIDS, DIABETES AND OBESITY

2:00 – 2:10 PM

Pre-Section Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
2:10 – 2:40 PM

Dyslipidemia Management: Looking Beyond LDL-C
Claude Lardinois, MD, FACP, MACN, FACE
Objectives

  1. Describe the limitations of using LDL-C as the target for therapy in patients with diabetes
  2. Identify the usefulness of using Non-HDL-C, TC/HDL-C ratio and APO-B as predictors of cardiovascular disease risk
  3. Recommend various treatment modalities (therapeutic life-style changes, genetics, non-invasive testing, inflammatory biomarkers, and drug therapy) that can reduce cardiovascular disease
2:40 – 3:10 PM

Obesity: Updated and Management
David Howard, MD, PhD, FACP
Objectives

  1. Understand the trends and approach to patients with excessive weight
  2. Understand the concept of metabolic adaptation as it applies to maintenance of weight loss
  3. Appreciate the surgical and pharmaceutical options which may enhance weight loss
3:10 – 3:50 PM

What's Hot in Diabetes Care
Fred Toffel, MD, FACP, FACE
Objectives

  1. Be familiar with the AACE Type 2 Diabetes algorithm
  2. Be familiar with some of the new medications to treat diabetes
  3. Be familiar with some of the new technologies to help manage diabetes
3:50 – 4:05 PM

Q and A

4:05 – 4:10 PM

Post Section Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
4:15 PM

Wrap Up and Adjournment

Sunday, October 7, 2018 – NV AACE Annual Meeting

8:00 – 8:50 AM

Registration and Breakfast

8:50 – 9:00 AM

Welcome

9:00 – 9:10 AM

Pre-Meeting Assessment
Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
9:00 – 10:00 AM

Uncommon Bone Diseases
Pauline Camacho, MD, FACE
Objectives

  1. Discuss the clinical presentation and treatment of osteogenesis imperfecta
  2. Discuss the clinical presentation and treatment of hypophosphatasia, specifically the adult form
  3. Discuss the clinical presentation and treatment of fibrous dysplasia
10:00 – 10:10 AM

Q and A

10:10 – 11:00 AM

Cardiovascular Risk Reduction in Diabetic Patients
Terrance Moran, MD, FACC, FAHA, FNLA
Objectives

  1. Determine CV risk in diabetic patients
  2. Understand the various guidelines for lipid management
  3. Comprehend the various medical options for risk reduction
11:00 – 11:10 AM

Q and A

11:10 – 11:15 AM

Post Meeting Assessment
Objectives

  1. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
11:15 – 12:00 PM

Business Meeting

12:00 – 12:10 PM

Closing Remarks and Adjournment

ATLANTIS CASINO HOTEL
3800 S. VIRGINIA ST.
RENO, NV 89502
United States

* Lisa Abbott, MD
Northern Nevada Endocrinology
Reno, NV

* Bijan Ahrari, MD, ECNU
Endocrinologist
Palm Medical Group
Las Vegas, NV

Pauline M. Camacho, MD, FACE
Professor of Medicine
Loyola University Medical Center
Director
Loyola University Osteoporosis and Metabolic Bone Disease Center
Immediate Past President
American Association of Clinical Endocrinologists
Maywood, IL

David J. Howard, MD, PhD, FACP
Assistant Professor of Medicine
Endocrinology, Diabetes, and Metabolism
University of Nevada, Reno School of Medicine
Reno, NV

* Kenneth Izuora, MD, MBA, FACE
Associate Professor of Medicine
University of Nevada Las Vegas School of Medicine
Las Vegas, NV

* Claude K. Lardinois, MD, FACP, MACN, FACE
Emeritus Professor of Medicine
University of Nevada School of Medicine
Reno, NV
Board Certified Endocrinology Consultant
Medical Director, American Health Care
Rocklin, CA

W. Reid Litchfield, MD, FACE, ECNU
Desert Endocrinology
Henderson, NV

Terrance Moran, MD, FACC, FAHA, FLNA
Director of Advanced Lipid Management
Prima Heart
Monterey, CA

Quang T. Nguyen, DO, FACE, FTOS
Medical Director, Las Vegas Endocrinology
Clinical Associate Professor, AZCOM
Adjunct Associate Professor, TUNCOM
Henderson, NV

Fariba Rahnema, MD, FACE, ECNU
Valley Endocrinology
Las Vegas, NV

John A. Seibel, MD, FACP, MACE
Atrinea Health
Albuquerque, NM

Fred Toffel, MD, FACP, FACE
Medical Director, Diabetes Treatment Center at Desert Springs Hospital
Adjunct Associate professor of Medicine
Touro University – Nevada, College of Osteopathic Medicine
Las Vegas, NV

* Paul V. Tomasic, MD, MS, FACP, FACE
Immediate Past President, Nevada Chapter of AACE
Endocrinologist
HealthCare Partners - Nevada
Las Vegas, NV

Nick Vernetti, MD, FACE
Endocrinologist
Palm Medical Group
Las Vegas, NV

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the Nevada Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 9.50 AMA
  • 9.50 Attendance

Accreditation Period

Course opens: 
10/05/2018
Course expires: 
10/07/2019

Price

Cost:
$0.00
Please login or register to take this course.